East Asia Pharmaceutical (605177.SH) released results for the first three quarters, with a net loss of 197 million yuan to mother

Zhitongcaijing · 2d ago

According to the Zhitong Finance App, East Asia Pharmaceutical (605177.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 609 million yuan, an increase of 2.12% over the previous year; loss of net profit attributable to shareholders of listed companies was 197 million yuan, after deducting loss of 207 million yuan in non-net profit; and basic earnings per share - 1.72 yuan.